Trial Information
Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
Inclusion Criteria:
- A. Clinically and radiologically suspected lung adenocarcinoma
- B. Newly-diagnosed Stage I or II from the clinical work up including PET/CT
- C. Performance status of 0 to 1 on the ECOG scale
- D. Age 20 years or older
- E. Able to tolerable DECT imaging required by protocol
- F. Able to give study-specific informed consent
Exclusion Criteria:
- A. Prior malignancy
- B. planning of Definitive RTx 나 neoadjuvant CCRTx
- C. Poor cardiopulmonary reserve
Type of Study:
Observational
Study Design:
Observational Model: Case Control, Time Perspective: Prospective
Outcome Measure:
Prediction of tumor aggressiveness
Outcome Time Frame:
five years
Safety Issue:
Yes
Principal Investigator
Young Mog Shim, Dr.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Samsung Medical Center
Authority:
South Korea: Institutional Review Board
Study ID:
SMC 2011-09-083
NCT ID:
NCT01482585
Start Date:
October 2011
Completion Date:
December 2016
Related Keywords:
- Lung Adenocarcinoma
- lung adenocarcinoma
- prognosis
- tumor aggressiveness
- imaging biomarker
- genetic biomarker
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- Lung Neoplasms